—

Medacta Group SA (MOVE.SW) — the peer cohort

As of 2026-11-18 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Medacta Group SA ranks 7 of 7 in its cohort on the Closelooknet composite (49/100) — the cohort is led by DexCom Inc at 62/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
MOVE.SW Medacta Group SA 49 20 58 31 warn 40.4%
DXCM DexCom Inc 62 70 78 35 watch 11.4%
CEVI.ST CellaVision AB 61 96 72 26 watch 2.2%
GMED Globus Medical 61 30 66 57 bear 31%
SECT-B.ST Sectra AB (publ) 60 87 67 10 bull 7.8%
SOON.SW Sonova H Ag 59 94 74 45 neutral 2.1%
SNN Smith & Nephew SNATS Inc 58 54 56 69 info 17%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-18

Quick answers

Who are Medacta Group SA's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: DexCom Inc (DXCM), CellaVision AB (CEVI.ST), Globus Medical (GMED), Sectra AB (publ) (SECT-B.ST), Sonova H Ag (SOON.SW), Smith & Nephew SNATS Inc (SNN), as of 2026-11-18.

How does MOVE.SW score against its peers?

Medacta Group SA's composite reads 49/100, ranking 7 of 7 in its cohort as of 2026-11-18; the cohort's highest composite is DexCom Inc at 62/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.